K-numberK242135
Device nameSynthgene Home Test HCG Test Strip; Synthgene Home Test HCG Test Cassette; Synthgene Home Test HCG Test Midstream
ApplicantNanjing Synthgene Medical Technology Co., Ltd.
Product codeLCX
Device classClass II
Decision dateJan 31, 2025
DecisionSubstantially Equivalent
Regulation862.1155
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Synthgene Home Test HCG Test is an over-the-counter immunochromatographic assay for qualitative detection of human chorionic gonadotropin (HCG) in urine to aid early detection of pregnancy. The device is offered in three formats: strip, cassette, and midstream, each containing a ready-to-use test component, urine cup, medical waste bag, and instructions for use.

Technological characteristics

The candidate device uses a double antibody sandwich immunochromatographic assay with colloidal gold-labeled antibodies on a nitrocellulose membrane. Sensitivity is 25 mIU/mL with qualitative results (positive/negative). The primary difference from the predicate is reading time: candidate requires 5–20 minutes versus predicate's 5 minutes. All other characteristics—specimen type (urine), assay methodology, sensitivity, results format, intended user (over-the-counter), and device formats—are identical to the predicate.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Substantial equivalence is established through: (1) identical intended use, specimen type, assay methodology, and sensitivity (25 mIU/mL) as the predicate; (2) comprehensive analytical testing demonstrating 100% accuracy at clinically relevant HCG concentrations with no interference from 31 endogenous and exogenous substances, pH variations (4–9), or specific gravity changes (1.000–1.035); (3) method comparison studies on 333 clinical samples across all three formats showing 100% concordance with predicate results; (4) lay-user studies confirming ease of use and correct result interpretation; and (5) no hook effect observed up to 1,860,000 mIU/mL. The longer reading window is a minor, non-safety-critical difference that does not affect clinical performance or safety profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →